458 results on '"Cardin, R."'
Search Results
2. OC.07.3 AUTOIMMUNE ATROPHIC GASTRITIS: DIFFERENCES BETWEEN HELICOBACTER PYLORI ASSOCIATED AND NON-ASSOCIATED DISEASE
3. T.08.6 CIRCULATING MICRORNA-21 AND HIF-1ALPHA IN CHRONIC LIVER DISEASES AND HEPATOCELLULAR CARCINOMA
4. OC.07.6 THE ROLE OF HELICOBACTER PYLORI IN AUTOIMMUNE ATROPHIC GASTRITIS: DISEASE PHENOTYPE AND MIRNA EXPRESSION
5. Activation by Human Gastric Mucosa of Alimentary Procarcinogens
6. A Youth Perspective on Outdoor Recreation.
7. OC.04.6 CIRCULATING PROSTAGLANDIN E2: A NOVEL POTENTIAL PROGNOSTIC BIOMARKER IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
8. AF.56 COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
9. AF.48 COMPARATIVE ASSESSMENT OF ADALIMUMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
10. OC.05.1 IDENTIFICATION OF MARKERS OF OXIDATIVE STRESS IN CELIAC DISEASE
11. P329 Comparative Assessment of Adalimumab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease
12. P295 Comparative Assessment of Infliximab Trough Levels between Point-of-Care Testing and current Standard of Care (enzyme linked immunosorbent assay) in patients with Inflammatory Bowel Disease
13. Letter: coffee and chronic liver damage
14. Circulating prostaglandin E2: A novel potential prognostic biomarker in patients with hepatocellular carcinoma
15. Effects of iron deprivation or chelation on DNA damage in experimental colitis
16. Coffee, chronic diseases and cancer
17. OC.05.6 GENDER-RELATED DIFFERENCES IN SCCA-IGM LEVELS IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION
18. OC.05.3 ENDOTHELIAL DAMAGE IN THE PORTAL VEIN OF PATIENTS WITH CIRRHOSIS
19. OC.05.1 MICRORNA-21 AND MICRORNA-122: PROGNOSIS PREDICTION AND CORRELATION WITH HIF-1ALPHA IN HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH TRANSARTERIAL CHEMOEMBOLIZATION
20. SCCA-IgM in hepatocellular carcinoma patients treated with transarterial chemoembolization: gender-related differences
21. Protection Against Genital HSV-2 in Guinea Pigs with Subunit Vaccines Containing gD2, gB2, and gH/gL Glycoprotein Antigens Complexed with CLDC Adjuvant: 24
22. Fas/FasL system, IL-1β expression and apoptosis in chronic HBV and HCV liver disease
23. DIFFERENT MODULATION OF AUTOPHAGY FLOW IN PRIMARY AND SECONDARY LIVER CANCER
24. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma
25. Zinc, iron, and peroxidation in liver tissue: Cumulative effects of alcohol consumption and virus-mediated damage—A preliminary report
26. Potent Antiviral Activity of REP9 and Analogs Against Vaginal HSV-2 Infection: 20
27. Pathology
28. Oxidative DNA Damage at Gastroesophageal Junction and H. pylori Eradication
29. H. pylori Infection Rate, gastric Malignancies and Precancerous Changes in a Secluded Population of North-east Italy. Time Trends
30. Tumor Necrosis Factor Alpha, Interferon Gamma, IL10 Host Gene Polymorphisms and H. pylori Infection
31. Identification of New IL12A (p35) and IL12B (p40) Genes Polymorphisms as Host Genetic Factors Interplaying With H. pylori
32. Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease 1
33. OC.12.4 RAPID POINT-OF-CARE MONITORING OF ANTI-INFLIXIMAB ANTIBODIES AND CLINICAL SCORES IN INFLAMMATORY BOWEL DISEASE PATIENTS
34. OC.06.1 THE IMMUNITY-INFLAMMATION-CANCER PATHWAY IN AUTOIMMUNE GASTRITIS: ROLE OF THE OXIDATIVE STRESS
35. P.07.28 PREVIOUS EXPOSURE TO INFLIXIMAB INDUCES CROSS-REACTIVITY AND AFFECTS ADALIMUMAB TROUGH LEVELS: DATA FROM A PROSPECTIVE, MULTICENTRE STUDY
36. P650 Mechanisms of Infliximab failure: the predictive role of MMP3
37. P475 Rapid point-of-care anti-drug antibodies measurement correlates with standardised T tests and facilitate a proactive therapeutic drug monitoring approach in IBD patients on anti-TNF-α maintenance therapy
38. Oxidative DNA damage accumulation in gastric carcinogenesis
39. APOPTOSIS AND CYTOPROLIFERATION IN CHRONIC HCV-RELATED HEPATITIS
40. P.01.20 FREE RADICALS AND OXIDATIVE STRESS-RELATED GENOMIC DAMAGE:WHICH ROLE IN AUTOIMMUNE GASTRITIS?
41. P.02.7 MMP3 (METALLOPROTEINASE 3): A NEW MARKER FOR ASSESSING LOSS OF RESPONSE TO INFLIXIMAB IN IBD
42. P726 Metalloproteinase 3: A new marker for assessing loss of response to infliximab in IBD
43. Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis
44. The role of anti-oxidants in the chemoprevention of gastric cancer
45. Determinants for the development of chronic atrophic gastritis and intestinal metaplasia in the stomach
46. Direct involvement of human gastric mucosa in the activation of alimentary pro-carcinogens
47. Circulating microRNA-21 and microRNA-122: prognosis prediction and correlation with HIF-1alpha in hepatocellular carcinoma patients treated with transarterial chemoembolization
48. P.09.9: Vascular Endothelial Growth Factor and Hypoxia Inducible Factor: Prognostic Role in HCC Patients Undergoing Conventional and Deb-Mediated Chemoembolization
49. Abnormal microvasculature in chronic viral hepatitis
50. Prognostic role of vascular endothelial growth factor and hypoxia inducible factor in HCC patients after conventional and DEB-mediated chemoembolization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.